Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.93 AUD | +1.64% | +21.57% | +200.00% |
Business Summary
Number of employees: 83
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Adult Stem Cell Technology
100.0
%
| 14 | 100.0 % | 11 | 100.0 % | -20.80% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia, United States and Singapore
100.0
%
| 14 | 100.0 % | 11 | 100.0 % | -20.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Silviu Itescu
FOU | Founder | 67 | 07/06/04 |
Andrew Chaponnel
DFI | Director of Finance/CFO | - | 31/05/12 |
Chief Operating Officer | 60 | 23/07/20 | |
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 73 | 14/04/13 |
Paul Hughes
IRC | Investor Relations Contact | - | 31/01/19 |
Niva Sivakumar
SEC | Corporate Secretary | - | 31/12/13 |
Paul Simmons
PRN | Corporate Officer/Principal | - | 31/12/10 |
General Counsel | - | 30/11/15 | |
Peter Howard
LAW | General Counsel | - | 30/06/11 |
Michael Schuster
PRN | Corporate Officer/Principal | - | 31/12/03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 73 | 14/04/13 |
Joseph Swedish
CHM | Chairman | 72 | 17/06/18 |
William Burns
BRD | Director/Board Member | 76 | 05/03/14 |
Philip Facchina
BRD | Director/Board Member | 62 | 28/03/21 |
Silviu Itescu
FOU | Founder | 67 | 07/06/04 |
Jane Bell
BRD | Director/Board Member | - | 17/08/22 |
Philip Krause
BRD | Director/Board Member | - | 23/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,015,342,237 | 891,403,655 ( 87.79 %) | 542,903 ( 0.0535 %) | 87.79 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.00% | 692M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MSB Stock
- Company Mesoblast Limited